Raising Health

Eren Bali, founder and CEO of Carbon Health, and Max Cohen, cofounder and CEO of Sprinter Health, discuss their experiences transitioning from tech to healthcare, finding product-market fit, tracking KPIs, and adapting to changes in the investor landscape. They reflect on the complexity of the healthcare industry, the challenges of addressing individual needs, and the advantages and opportunities for tech companies in healthcare

Joe Grogan, senior fellow at the Leonard D. Schaeffer Center for Health Policy and Economics, discusses his experience during the early days of the COVID pandemic. He shares insights on the Inflation Reduction Act's impact on pharmaceutical R&D and the future of AI regulation.

Rahul Kakkar, John Finn, and Jorge Conde discuss PASTE, a genome editing technique that could make cell therapy more accessible. They explore advancements in genomic medicine, CRISPR technology, and focus on genetic diseases of the liver and autoimmune diseases. They also touch on challenges in transitioning from research to patients and share anecdotes about facial hair.

Vijay Pande, founding partner of Bio + Health, discusses the evolution of AI, the pioneers in the field, and the shift to biology. He highlights the advancements in biology, the challenges of obtaining data, and the importance of multiple perspectives in understanding cells. The podcast also explores the opportunities in AI startups and how AI is being integrated into life sciences and healthcare companies.

Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande to discuss the building and growth of Omada, the future of AI in healthcare, and the challenges of using technology in a caregiving environment. They also reflect on their personal and professional development over the years and highlight innovative solutions to scaling healthcare.

The podcast 'Raising Health' explores technological advancements in healthcare, including analyzing health data, personalized recommendations, gene therapy, and the role of artificial intelligence in healthcare.

Pranav Rajpurkar, PhD discusses the future of generalist medical AI, its potential as a support system for physicians, and the challenges of developing a model encompassing all medical knowledge. They explore the transition to deep learning, feasibility of building a generalist AI, and the timeline for its arrival.

Jordi Mata-Fink, co-founder of Gate Bioscience, discusses their work on commercializing a novel class of therapeutics called 'molecular gates' targeting extracellular proteins. He explores the power of platform-based problem-solving and team building in biotech startups, as well as the potential of small molecules to overcome therapeutic challenges. The episode also delves into the secretory translocon and the opportunities it presents for therapeutic intervention.

Mario Schlosser, Cofounder and President of Technology at Oscar Health, explores how AI can revolutionize traditional healthcare by enhancing efficiency, personalizing care journeys, and integrating real-time data insights. They discuss benefit-less benefit designs, the role of incentives in member behavior, and the potential for machine learning to improve outcomes. They also touch on the future of networks in healthcare and the impact of AI on affordability, efficiency, and member experience.

Miriam Vogel, President and CEO of EqualAI, discusses ethical integration of AI, concrete steps to build trustworthy AI, the regulatory landscape, and the state of politics around AI. Topics include addressing bias and hidden harms in AI, regulatory framework and best practices for AI, pressing ethical challenges and creating a better society with AI, and the ethical concerns of AI-generated visuals.